Skip to content

Improving community-based mental health care in India and Pakistan

Improving outcomes for people with psychosis in Pakistan and India – enhancing the Effectiveness of Community-based care (PIECEs)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13022816
Enrollment
420
Registered
2022-02-09
Start date
2022-03-07
Completion date
Unknown
Last updated
2025-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improving the quality of life for individuals with long-term psychosis (duration of >2 years) Mental and Behavioural Disorders Unspecified nonorganic psychosis

Interventions

This is a cluster randomised control trial where clinicians and their respective enrolled patients will form clusters that will be randomised into a treatment and active control arm. The total duratio

Sponsors

National Institute for Health Research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of psychosis, currently not receiving inpatient treatment, with a duration of illness greater than 2 years Patients: 1. Diagnosis of psychosis 2. Aged over 18 years 3. Capacity for informed consent 4. Can speak and understand the local language 5. Has a low quality of life (<5 on the MANSA) Clinicians: 1. Any professional background or lay community worker 2. Regular contact with patients with psychosis

Exclusion criteria

Exclusion criteria: Patients: 1. Dementia and/or significant cognitive impairment and/or severe learning disability 2. Organic psychosis or drug-induced psychosis if given as the primary diagnosis 3. Unable to provide informed consent Clinicians: 1. Does not have regular contact with individual(s) with chronic psychosis 2. Unable to speak either Urdu or Tamil

Design outcomes

Secondary

MeasureTime frame
1. Hospitalisation measured using the Client Service Resource Inventory (CSRI) at baseline, 6 and 12 months 2. Symptoms measured using the Brief Psychiatric Rating Scale (BPRS) at baseline, 6 and 12 months 3. Negative symptoms measured using the Scale for the Assessment of Negative Symptoms (SANS) at baseline, 6 and 12 months 4. Objective social situation measured using the Objective Social Outcomes Index (SIX) at baseline, 6 and 12 months 5. Therapeutic alliance measured using the Helping Alliance Questionnaire (HAQ-II) at baseline, 6 and 12 months 6. Health-related quality of life measured using EQ5D-3L at baseline, 6 and 12 months 7. Service use measured using the Client Service Receipt Inventory (CSRI) at baseline, 6 and 12 months

Primary

MeasureTime frame
Subjective quality of life measured using the Manchester Short Assessment of Quality of Life (MANSA) at baseline, 6 and 12 months

Countries

India, Pakistan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 12, 2026